Shanghai Junshi Biosciences Co., Ltd. Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Xiong Jun, was filed 08 Apr 2026.
Shanghai Junshi Biosciences Co., Ltd.: what insiders have been doing
Shanghai Junshi Biosciences Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through HKEX. Between 31 October 2025 and 31 October 2026, 2 insiders published 5 filings.
Every open-market trade in the period is a purchase: 5 purchases worth €10.7M, from 2 insiders, and not a single sale. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Xiong Jun filed the largest purchase, €7.7M, on 8 April 2026, which represents 0.37% of the company's market value.
The most recent open-market purchase was published on 8 April 2026, 214 days ago. Typically, a trade is published a median of 8 days after it takes place. That lag is the time during which only the insider knows about the trade.
Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark. The full history, which starts in 2026, counts 5 purchases against no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -36.6%Entry HK$25.04 · Close 29 Oct 2026 HK$15.88
- -36.6%Entry HK$25.04 · Close 29 Oct 2026 HK$15.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Shanghai Junshi Biosciences Co., Ltd. Strong Buy (bullish), based on 4 analysts. Average price target: HK$31.76.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,999,513 shares@ HK$34.81150.37% mcap71.8% of flowShareXHKGHKEX:DA20260403E00020Canonical exit: 29 Jun 2026 (T+90)
- 894,600 shares@ HK$21.04340.10% mcap19.4% of flowShareXHKGHKEX:DA20260403E00021Canonical exit: 29 Jun 2026 (T+90)
- 894,600 sharesShareXHKGHKEX:DA20260403E00027Canonical exit: 29 Jun 2026 (T+90)
- 1,999,513 sharesShareXHKGHKEX:DA20260403E00026Canonical exit: 29 Jun 2026 (T+90)
- 265,382 shares@ HK$31.53260.045% mcap8.8% of flowShareXHKGHKEX:DA20260319E00117Canonical exit: 14 Jun 2026 (T+90)
5 of 5 declarations
About Shanghai Junshi Biosciences Co., Ltd.
Shanghai Junshi Biosciences Co., Ltd. is a biopharmaceutical company focused on the research and development of innovative drugs. It specializes in biological therapies for the treatment of serious diseases.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
